Illumina
Overview

Date: On-Demand

Watch Now

The Northern Territory of Australia, retains a unique and substantially diverse range of infectious diseases, thus highlighting the necessity of offering rapid, reliable and cost-effective diagnostic and epidemiological surveillance methods. Due to the immense global pressure for epidemiological surveillance of the SARS-CoV-2 virus, rural and remote laboratories such as Territory Pathology were provided with the opportunity to establish local NGS capacity. As the burden of the SARS-CoV-2 begun to decrease, Territory Pathology begun to explore the utility of NGS together with Illumina for other infectious diseases via both whole genome sequencing (WGS), capture/hybridization, amplicon and other shotgun metagenomics methods. These explorations have established Territory Pathology as a unique laboratory containing a wide range of NGS methods.

The three key things you'll learn in this webinar are:

  • How the Northern Territory of Australia established local capacity for NGS
  • Challenges and future projections
  • Utility of Illumina DNA prep, Illumina RPIP, VSP, UPIP, and BaseSpace™ Sequence hub in a laboratory setting

Speaker:

Dimitrios Menouhos
Molecular Biology Supervising Scientist ,
Territory Pathology, Australia

Mr. Menouhos has been an employee of Territory Pathology of the Royal Darwin Hospital located in the Northern Territory of Australia for almost a decade and is currently the Molecular Biology Supervising Scientist of the department of Serology/Molecular Biology. Mr. Menouhos completed a bachelor of Medical Laboratory Science degree in 2016 and subsequently undertook a bachelor of Science Honours project with Charles Darwin University. In 2019, Mr. Menouhos was awarded with a bachelor of Science First-Class Honors degree for his research project titled ‘Development and application of targeted genotyping to enhance surveillance of sexually transmitted infections in the Northern Territory’.

In 2020, during the SARS-CoV-2 pandemic Mr. Menouhos undertook a Masters of Diagnostic Genomics through the Queensland University of Technology, which during the SARS-CoV-2 pandemic assisted Mr. Menouhos in establishing the first and only local Next-Generation Sequencing (NGS) capacity in the Northern Territory. Mr. Menouhos’s interests include the design and development of molecular/genetic assays for the diagnosis, epidemiological, and antimicrobial surveillance of infectious and tropical diseases. Furthermore, Mr. Menouhos retains a passion for human cancer genomics as well as sharing his experiences in order to assist rural area laboratories to establishing capacity for molecular and/or genetic services.

View all the webinars in the Illumina One Health and Sustained Pathogen Surveillance Webinar Series.

M-GL-01844